Potent Targeted Therapy for resistant CML and Ph+ ALL with Ponaxen 15mg

It is an targeted cancer therapy, a potent tyrosine kinase inhibitor. Healthcare professionals prescribe Ponaxen 15mg for Chronic Myeloid Leukemia [CML] and Philadelphia chromosome positive acute lymphoblastic leukemia [Ph+ALL] in adults. It is primarily prescribed for adults resistant to other therapies or those with the T3151 mutation. To know more in detail about the medicine visit Globans Pharma website.